Ibnsina Pharma (EGX: ISPH)

Market Cap	3.68B
Revenue (ttm)	42.06B
Net Income (ttm)	250.97M
Shares Out	1.01B
EPS (ttm)	0.25
PE Ratio	14.66
Forward PE	9.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,974,036
Open	3.700
Previous Close	3.700
Day's Range	3.650 - 3.790
52-Week Range	1.780 - 4.150
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2023, Ibnsina Pharma's revenue was 33.95 billion, an increase of 52.48% compared to the previous year's 22.26 billion. Earnings were 173.14 million, an increase of 27.65%.